Ranpak Holdings Corp. (PACK) · Insider trading
What Ranpak Holdings's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
$0
bought less sold
Latest filing
2026-10-05
filings read to 2026-10-19
No director, officer or large holder of Ranpak Holdings reported buying or selling at the market price in the last two years. What they did report is below.
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
60 × grant or award22 × shares withheld for tax
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-01 | Jones Michael AnthonyDirector | Grant or award A | +4,606 | 4.07 | 297,233 | Form 4 |
| 2026-10-01 | Seshadri SalilDirector | Grant or award A | +4,606 | 4.07 | 579,857 | Form 4 |
| 2026-10-01 | Tranen Alicia M.Director | Grant or award A | +4,606 | 4.07 | 326,741 | Form 4 |
| 2026-07-01 | Seshadri SalilDirector | Grant or award A | +2,713 | 6.91 | 575,251 | Form 4 |
| 2026-07-01 | Jones Michael AnthonyDirector | Grant or award A | +2,713 | 6.91 | 292,627 | Form 4 |
| 2026-07-01 | Tranen Alicia M.Director | Grant or award A | +2,713 | 6.91 | 322,135 | Form 4 |
| 2026-05-21 | Tranen Alicia M.Director | Grant or award A | +16,181 | – | 319,422 | Form 4 |
| 2026-05-21 | Seshadri SalilDirector | Grant or award A | +16,181 | – | 572,538 | Form 4 |
| 2026-05-21 | King Robert CDirector | Grant or award A | +16,181 | – | 188,288 | Form 4 |
| 2026-05-21 | Jones Michael AnthonyDirector | Grant or award A | +16,181 | – | 289,914 | Form 4 |
| 2026-05-21 | El Pamela K.Director | Grant or award A | +16,181 | – | 145,104 | Form 4 |
| 2026-05-21 | Dolan Victoria LDirector | Grant or award A | +16,181 | – | 45,506 | Form 4 |
| 2026-05-21 | Corley Thomas F.Director | Grant or award A | +16,181 | – | 122,387 | Form 4 |
| 2026-04-01 | Jones Michael AnthonyDirector | Grant or award A | +5,179 | 3.62 | 273,733 | Form 4 |
| 2026-04-01 | Tranen Alicia M.Director | Grant or award A | +5,179 | 3.62 | 303,241 | Form 4 |
| 2026-04-01 | Seshadri SalilDirector | Grant or award A | +5,179 | 3.62 | 556,357 | Form 4 |
| 2026-03-10 | Asali OmarDirector, CEO & Executive Chairman | Shares withheld for tax F | −60,937 | 3.83 | 2,728,533 | Form 4 |
| 2026-03-10 | Aram PaulChief Operating Officer (COO) | Shares withheld for tax F | −950 | 3.83 | 29,800 | Form 4 |
| 2026-03-10 | Drew WilliamChief Financial Officer & EVP | Shares withheld for tax F | −17,830 | 3.83 | 544,018 | Form 4 |
| 2026-03-10 | Gliedman Michael S.Director | Shares withheld for tax F | −12,686 | 3.83 | 160,327 | Form 4 |
| 2026-03-05 | Aram PaulChief Operating Officer (COO) | Grant or award A | +750 | – | 30,750 | Form 4 |
| 2026-03-05 | Asali OmarDirector, CEO & Executive Chairman | Grant or award A | +13,803 | – | 2,789,470 | Form 4 |
| 2026-03-05 | Drew WilliamChief Financial Officer & EVP | Grant or award A | +4,602 | – | 561,848 | Form 4 |
| 2026-03-05 | Gliedman Michael S.Director | Grant or award A | +3,750 | – | 173,013 | Form 4 |
| 2026-03-03 | Asali OmarDirector, CEO & Executive Chairman | Grant or award A | +92,026 | – | 2,775,667 | Form 4 |
| 2026-03-03 | Aram PaulChief Operating Officer (COO) | Grant or award A | +25,000 | – | 30,000 | Form 4 |
| 2026-03-03 | Drew WilliamChief Financial Officer & EVP | Grant or award A | +30,675 | – | 557,246 | Form 4 |
| 2026-03-03 | Gliedman Michael S.Director | Grant or award A | +25,000 | – | 169,263 | Form 4 |
| 2026-01-02 | Seshadri SalilDirector | Grant or award A | +3,390 | 5.53 | 551,178 | Form 4 |
| 2026-01-02 | Tranen Alicia M.Director | Grant or award A | +3,390 | 5.53 | 298,062 | Form 4 |
| 2026-01-02 | Asali OmarDirector, CEO & Executive Chairman | Shares withheld for tax F | −46,552 | 5.53 | 2,683,641 | Form 4 |
| 2026-01-02 | Drew WilliamChief Financial Officer & EVP | Shares withheld for tax F | −14,823 | 5.53 | 526,571 | Form 4 |
| 2026-01-02 | Gliedman Michael S.Director | Shares withheld for tax F | −8,287 | 5.53 | 144,263 | Form 4 |
| 2026-01-02 | Jones Michael AnthonyDirector | Grant or award A | +3,390 | 5.53 | 268,554 | Form 4 |
| 2025-10-28 | Aram PaulChief Operating Officer (COO) | Grant or award A | +5,000 | – | 5,000 | Form 4 |
| 2025-10-01 | Tranen Alicia M.Director | Grant or award A | +3,372 | 5.56 | 294,672 | Form 4 |
| 2025-10-01 | Seshadri SalilDirector | Grant or award A | +3,372 | 5.56 | 547,788 | Form 4 |
| 2025-10-01 | Jones Michael AnthonyDirector | Grant or award A | +3,372 | 5.56 | 265,164 | Form 4 |
| 2025-07-01 | Jones Michael AnthonyDirector | Grant or award A | +5,179 | 3.62 | 261,792 | Form 4 |
| 2025-07-01 | Seshadri SalilDirector | Grant or award A | +5,179 | 3.62 | 544,416 | Form 4 |
| 2025-07-01 | Tranen Alicia M.Director | Grant or award A | +5,179 | 3.62 | 291,300 | Form 4 |
| 2025-05-22 | El Pamela K.Director | Grant or award A | +29,325 | – | 128,923 | Form 4 |
| 2025-05-22 | Seshadri SalilDirector | Grant or award A | +29,325 | – | 539,237 | Form 4 |
| 2025-05-22 | Corley Thomas F.Director | Grant or award A | +29,325 | – | 106,206 | Form 4 |
| 2025-05-22 | Dolan Victoria LDirector | Grant or award A | +29,325 | – | 29,325 | Form 4 |
| 2025-05-22 | Jones Michael AnthonyDirector | Grant or award A | +29,325 | – | 256,613 | Form 4 |
| 2025-05-22 | Tranen Alicia M.Director | Grant or award A | +29,325 | – | 286,121 | Form 4 |
| 2025-05-22 | King Robert CDirector | Grant or award A | +29,325 | – | 172,107 | Form 4 |
| 2025-04-01 | Jones Michael AnthonyDirector | Grant or award A | +3,605 | 5.20 | 227,288 | Form 4 |
| 2025-04-01 | Seshadri SalilDirector | Grant or award A | +3,605 | 5.20 | 509,912 | Form 4 |
| 2025-04-01 | Tranen Alicia M.Director | Grant or award A | +3,605 | 5.20 | 256,796 | Form 4 |
| 2025-03-17 | Siebert Mark A.MD, North America | Grant or award A | +20,500 | – | 111,904 | Form 4 |
| 2025-03-17 | Siebert Mark A.MD, North America | Shares withheld for tax F | −2,372 | 6.02 | 109,532 | Form 4 |
| 2025-03-17 | Laurensse EricManaging Director, Europe | Grant or award A | +35,058 | – | 211,834 | Form 4 |
| 2025-03-17 | Laurensse EricManaging Director, Europe | Shares withheld for tax F | −5,785 | 6.02 | 206,049 | Form 4 |
| 2025-03-17 | Grassotti AntonioManaging Director, APAC | Grant or award A | +20,344 | – | 188,856 | Form 4 |
| 2025-03-17 | Gliedman Michael S.Director | Grant or award A | +17,529 | – | 155,007 | Form 4 |
| 2025-03-17 | Gliedman Michael S.Director | Shares withheld for tax F | −2,457 | 6.02 | 152,550 | Form 4 |
| 2025-03-17 | Drew WilliamChief Financial Officer & EVP | Grant or award A | +30,675 | – | 545,213 | Form 4 |
| 2025-03-17 | Drew WilliamChief Financial Officer & EVP | Shares withheld for tax F | −3,819 | 6.02 | 541,394 | Form 4 |
| 2025-03-17 | Asali OmarDirector, CEO & Executive Chairman | Grant or award A | +92,027 | – | 2,744,409 | Form 4 |
| 2025-03-17 | Asali OmarDirector, CEO & Executive Chairman | Shares withheld for tax F | −14,216 | 6.02 | 2,730,193 | Form 4 |
| 2025-03-10 | Asali OmarDirector, CEO & Executive Chairman | Shares withheld for tax F | −32,877 | 5.72 | 2,652,382 | Form 4 |
| 2025-03-10 | Gliedman Michael S.Director | Shares withheld for tax F | −6,154 | 5.72 | 137,478 | Form 4 |
| 2025-03-10 | Laurensse EricManaging Director, Europe | Shares withheld for tax F | −14,573 | 5.72 | 176,776 | Form 4 |
| 2025-03-10 | Siebert Mark A.MD, North America | Shares withheld for tax F | −6,969 | 5.72 | 91,404 | Form 4 |
| 2025-03-10 | Drew WilliamChief Financial Officer & EVP | Shares withheld for tax F | −9,620 | 5.72 | 514,538 | Form 4 |
| 2025-03-04 | Drew WilliamChief Financial Officer & SVP | Grant or award A | +30,675 | – | 524,158 | Form 4 |
| 2025-03-04 | Siebert Mark A.MD, North America | Grant or award A | +18,450 | – | 98,373 | Form 4 |
| 2025-03-04 | Gliedman Michael S.Director | Grant or award A | +25,000 | – | 143,632 | Form 4 |
| 2025-03-04 | Grassotti AntonioManaging Director, APAC | Grant or award A | +18,309 | – | 168,512 | Form 4 |
| 2025-03-04 | Laurensse EricManaging Director, Europe | Grant or award A | +31,552 | – | 191,349 | Form 4 |
| 2025-03-04 | Asali OmarDirector, CEO & Executive Chairman | Grant or award A | +92,026 | – | 2,685,259 | Form 4 |
| 2025-01-02 | Siebert Mark A.MD, North America | Shares withheld for tax F | −8,000 | 6.78 | 79,923 | Form 4 |
| 2025-01-02 | Laurensse EricManaging Director, Europe | Shares withheld for tax F | −12,375 | 6.78 | 159,797 | Form 4 |
| 2025-01-02 | Drew WilliamChief Financial Officer & SVP | Shares withheld for tax F | −14,414 | 6.78 | 493,483 | Form 4 |
| 2025-01-02 | Tranen Alicia M.Director | Grant or award A | +2,765 | 6.78 | 253,191 | Form 4 |
| 2025-01-02 | Seshadri SalilDirector | Grant or award A | +2,765 | 6.78 | 506,307 | Form 4 |
| 2025-01-02 | El Pamela K.Director | Grant or award A | +2,765 | 6.78 | 99,598 | Form 4 |
| 2025-01-02 | Jones Michael AnthonyDirector | Grant or award A | +2,765 | 6.78 | 223,683 | Form 4 |
| 2025-01-02 | Gliedman Michael S.Director | Shares withheld for tax F | −8,287 | 6.78 | 118,632 | Form 4 |
| 2025-01-02 | Asali OmarDirector, CEO & Executive Chairman | Shares withheld for tax F | −46,153 | 6.78 | 2,593,233 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.